Bismacine

{{Short description|Patent medicine}}

Bismacine, also known as Chromacine, is a substance manufactured by American Biologics Corporation and marketed as a purported alternative treatment for Lyme disease. Bismacine contains high levels of bismuth, and two deaths are recorded following the use of intravenous bismacine to treat Lyme disease.{{cite journal | author=Quirk M. | title=Alternative health therapy for Lyme disease results in death | journal=Lancet Infect Dis | year=2006 | volume=6 | issue=8 | pages=546 | doi=10.1016/S1473-3099(06)70563-1 }} In 2006, the U.S. Food and Drug Administration warned consumers not to use bismacine, noting that it is ineffective and dangerous.{{cite web| publisher = U.S. Food and Drug Administration | date = 2006-06-21 | title = FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine | url = https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108696.htm | accessdate = 2008-10-16}}